A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese Men

NCT05742919 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-alcoholic Fatty Liver Disease

Interventions

DRUG: NNC0194-0499
DRUG: NNC0194-0499
DRUG: NC0194-0499

Sponsor

Novo Nordisk A/S